89 related articles for article (PubMed ID: 23510335)
1. Long-term preconditioning with erythropoietin reduces ischemia-induced skin necrosis.
Rezaeian F; Wettstein R; Scheuer C; Schenck TL; Egaña JT; Machens HG; Menger MD; Harder Y
Microcirculation; 2013 Nov; 20(8):693-702. PubMed ID: 23510335
[TBL] [Abstract][Full Text] [Related]
2. Erythropoietin protects critically perfused flap tissue.
Rezaeian F; Wettstein R; Amon M; Scheuer C; Schramm R; Menger MD; Pittet B; Harder Y
Ann Surg; 2008 Dec; 248(6):919-29. PubMed ID: 19092336
[TBL] [Abstract][Full Text] [Related]
3. Erythropoietin reduces necrosis in critically ischemic myocutaneous tissue by protecting nutritive perfusion in a dose-dependent manner.
Harder Y; Amon M; Schramm R; Contaldo C; Metzkow E; Matzen A; Rücker M; Vollmar B; Menger MD
Surgery; 2009 Apr; 145(4):372-83. PubMed ID: 19303985
[TBL] [Abstract][Full Text] [Related]
4. Erythropoietin-induced upregulation of endothelial nitric oxide synthase but not vascular endothelial growth factor prevents musculocutaneous tissue from ischemic damage.
Rezaeian F; Wettstein R; Egger JF; Sandmann F; Rücker M; Tobalem M; Vollmar B; Menger MD; Harder Y
Lab Invest; 2010 Jan; 90(1):40-51. PubMed ID: 19901910
[TBL] [Abstract][Full Text] [Related]
5. Long-term pre- and postconditioning with low doses of erythropoietin protects critically perfused musculocutaneous tissue from necrosis.
Schmauss D; Weinzierl A; Weiss F; Egaña JT; Rezaeian F; Hopfner U; Schmauss V; Machens HG; Harder Y
J Plast Reconstr Aesthet Surg; 2019 Apr; 72(4):590-599. PubMed ID: 30733080
[TBL] [Abstract][Full Text] [Related]
6. Local shockwave-induced capillary recruitment improves survival of musculocutaneous flaps.
Tobalem M; Wettstein R; Pittet-Cuénod B; Vigato E; Machens HG; Lohmeyer JA; Rezaeian F; Harder Y
J Surg Res; 2013 Oct; 184(2):1196-204. PubMed ID: 23582757
[TBL] [Abstract][Full Text] [Related]
7. EPO reverses defective wound repair in hypercholesterolaemic mice by increasing functional angiogenesis.
Elsherbiny A; Högger DC; Borozadi MK; Schmidt CA; Plock J; Largo RD; Lindenblatt N; Giovanoli P; Contaldo C
J Plast Reconstr Aesthet Surg; 2012 Nov; 65(11):1559-68. PubMed ID: 22704605
[TBL] [Abstract][Full Text] [Related]
8. N-acetylcysteine attenuates leukocytic inflammation and microvascular perfusion failure in critically ischemic random pattern flaps.
Bächle AC; Mörsdorf P; Rezaeian F; Ong MF; Harder Y; Menger MD
Microvasc Res; 2011 Jul; 82(1):28-34. PubMed ID: 21513718
[TBL] [Abstract][Full Text] [Related]
9. Ghrelin protects musculocutaneous tissue from ischemic necrosis by improving microvascular perfusion.
Rezaeian F; Wettstein R; Scheuer C; Bäumker K; Bächle A; Vollmar B; Menger MD; Harder Y
Am J Physiol Heart Circ Physiol; 2012 Feb; 302(3):H603-10. PubMed ID: 22159999
[TBL] [Abstract][Full Text] [Related]
10. Evolution of ischemic tissue injury in a random pattern flap: a new mouse model using intravital microscopy.
Harder Y; Amon M; Erni D; Menger MD
J Surg Res; 2004 Oct; 121(2):197-205. PubMed ID: 15501459
[TBL] [Abstract][Full Text] [Related]
11. Secondary burn progression decreased by erythropoietin.
Tobalem M; Harder Y; Rezaeian F; Wettstein R
Crit Care Med; 2013 Apr; 41(4):963-71. PubMed ID: 23324953
[TBL] [Abstract][Full Text] [Related]
12. Effect of erythropoietin on angiogenesis with the increased adhesion of platelets to the microvessels in the hind-limb ischemia model in mice.
Kato S; Amano H; Ito Y; Eshima K; Aoyama N; Tamaki H; Sakagami H; Satoh Y; Izumi T; Majima M
J Pharmacol Sci; 2010; 112(2):167-75. PubMed ID: 20134117
[TBL] [Abstract][Full Text] [Related]
13. The nonhematopoietic effects of erythropoietin in skin regeneration and repair: from basic research to clinical use.
Sorg H; Harder Y; Krueger C; Reimers K; Vogt PM
Med Res Rev; 2013 May; 33(3):637-64. PubMed ID: 22430919
[TBL] [Abstract][Full Text] [Related]
14. Effects of erythropoietin in skin wound healing are dose related.
Sorg H; Krueger C; Schulz T; Menger MD; Schmitz F; Vollmar B
FASEB J; 2009 Sep; 23(9):3049-58. PubMed ID: 19403513
[TBL] [Abstract][Full Text] [Related]
15. Co-delivery of G-CSF and EPO released from fibrin gel for therapeutic neovascularization in rat hindlimb ischemia model.
Chen F; Liu Q; Zhang ZD; Zhu XH
Microcirculation; 2013 Jul; 20(5):416-24. PubMed ID: 23294128
[TBL] [Abstract][Full Text] [Related]
16. Morphology and hemodynamics during vascular regeneration in critically ischemic murine skin studied by intravital microscopy techniques.
Schweizer R; Merz K; Schlosser S; Spanholtz T; Contaldo C; Stein JV; Enzmann V; Giovanoli P; Erni D; Plock JA
Eur Surg Res; 2011; 47(4):222-30. PubMed ID: 22056471
[TBL] [Abstract][Full Text] [Related]
17. Review of the role of erythropoietin in critical leg ischemia.
Joshi D; Tsui J; Ho TK; Selvakumar S; Abraham DJ; Baker DM
Angiology; 2010 Aug; 61(6):541-50. PubMed ID: 20462898
[TBL] [Abstract][Full Text] [Related]
18. A comparative study of recombinant human basic fibroblast growth factor (bFGF) and erythropoietin (EPO) in prevention of skin flap ischemic necrosis in rats.
Fayazzadeh E; Ahmadi SH; Rabbani S; Boroumand MA; Salavati A; Anvari MS
Arch Iran Med; 2012 Sep; 15(9):553-6. PubMed ID: 22924373
[TBL] [Abstract][Full Text] [Related]
19. Distinct microhemodynamic efficacy of arteriogenesis and angiogenesis in critically ischemic skin flaps.
Merz K; Schweizer R; Schlosser S; Giovanoli P; Erni D; Plock JA
Microvasc Res; 2012 Mar; 83(2):249-56. PubMed ID: 22080047
[TBL] [Abstract][Full Text] [Related]
20. Prevention of skin flap necrosis by estradiol involves reperfusion of a protected vascular network.
Toutain CE; Brouchet L; Raymond-Letron I; Vicendo P; Bergès H; Favre J; Fouque MJ; Krust A; Schmitt AM; Chambon P; Gourdy P; Arnal JF; Lenfant F
Circ Res; 2009 Jan; 104(2):245-54, 12p following 254. PubMed ID: 19059842
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
